{"nct_id":"NCT04707768","title":"Study Evaluating the Efficacy and Safety of Dose Conversion From a Long-acting Erythropoiesis-stimulating Agent (Mircera®) to Three Times Weekly Oral Vadadustat for the Maintenance Treatment of Anemia in Hemodialysis Subjects","status":"COMPLETED","status_verified_date":"2024-12","start_date":"2021-06-18","start_date_type":"ACTUAL","primary_completion_date":"2023-01-06","primary_completion_date_type":"ACTUAL","completion_date":"2023-01-30","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["AKBA"]}